非小细胞肺癌原发灶与转移部位驱动基因状态一致性的研究进展
Authors:
Open Access
- 27 February 2020
- journal article
- abstracts
- Vol. 23 (3) , 196-203
Abstract
非小细胞肺癌(non-small cell lung cancer, NSCLC)作为肺癌最常见的病理类型,具有恶性程度高和侵袭性强的特点,晚期极易发生淋巴结和不同脏器转移。近年来,随着精准医学应用的深入,不断出现NSCLC转移部位的耐药和治疗失效为分子靶向治疗带来困扰,研究证实这些可能与肿瘤转移后发生的分子学改变有关。本文旨在阐述NSCLC原发灶与转移部位驱动基因状态,系统性综述两者间驱动基因状态一致性的研究进展,为探讨转移性NSCLC的分子靶向治疗提供新的思路。Keywords
This publication has 45 references indexed in Scilit:
- Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutationsRespiratory Investigation, 2013
- Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinomaCancer Cytopathology, 2013
- Discordance between anaplastic lymphoma kinase status in primary non‐small‐cell lung cancers and their corresponding metastasesHistopathology, 2012
- EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinomaCellular Oncology, 2012
- EGFR Mutation Status in Primary Lung Adenocarcinomas and Corresponding Metastatic Lesions: Discordance in Pleural MetastasesClinical Lung Cancer, 2011
- EGFR Mutations and Lung CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node MetastasesClinical Cancer Research, 2009
- Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLCBritish Journal of Cancer, 2008
- Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugsCancer Letters, 2008
- Frequent EGFR mutations in brain metastases of lung adenocarcinomaInternational Journal of Cancer, 2006